Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003.
Publication
, Journal Article
Fleming, T; Borer, J; Armstrong, PW; Pfeffer, M; Food and Drug Administration. Cardiovascular and Renal Drugs Advisory Committee,
Published in: Circulation
January 21, 2003
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
January 21, 2003
Volume
107
Issue
2
Start / End Page
e9002 / e9003
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Treatment Outcome
- Stroke
- Risk
- Renin-Angiotensin System
- Receptor, Angiotensin, Type 1
- Randomized Controlled Trials as Topic
- Racial Groups
- Propanolamines
Citation
APA
Chicago
ICMJE
MLA
NLM
Fleming, T., Borer, J., Armstrong, P. W., Pfeffer, M., & Food and Drug Administration. Cardiovascular and Renal Drugs Advisory Committee, . (2003). Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003. Circulation, 107(2), e9002–e9003. https://doi.org/10.1161/01.cir.0000057552.70961.f3
Fleming, Thomas, Jeff Borer, Paul W. Armstrong, Marc Pfeffer, and Marc Food and Drug Administration. Cardiovascular and Renal Drugs Advisory Committee. “Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003.” Circulation 107, no. 2 (January 21, 2003): e9002–3. https://doi.org/10.1161/01.cir.0000057552.70961.f3.
Fleming T, Borer J, Armstrong PW, Pfeffer M, Food and Drug Administration. Cardiovascular and Renal Drugs Advisory Committee. Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003. Circulation. 2003 Jan 21;107(2):e9002–3.
Fleming, Thomas, et al. “Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003.” Circulation, vol. 107, no. 2, Jan. 2003, pp. e9002–03. Pubmed, doi:10.1161/01.cir.0000057552.70961.f3.
Fleming T, Borer J, Armstrong PW, Pfeffer M, Food and Drug Administration. Cardiovascular and Renal Drugs Advisory Committee. Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003. Circulation. 2003 Jan 21;107(2):e9002–e9003.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
January 21, 2003
Volume
107
Issue
2
Start / End Page
e9002 / e9003
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Treatment Outcome
- Stroke
- Risk
- Renin-Angiotensin System
- Receptor, Angiotensin, Type 1
- Randomized Controlled Trials as Topic
- Racial Groups
- Propanolamines